Biologist
US Food and Drug Administration (FDA)
Silver Spring, Maryland, United States
Dr. Jankowski is a research reviewer with the US Food and Drug Administration in the Office of Therapeutic Products. He is part of an active research laboratory, and his research interests lie in the regulatory-science associated with the licensure of the next generation of therapeutic proteins. A key focus of his research activities has been to understand the immune response to protein therapeutics, which can significantly affect the efficacy and safety of these drugs. He uses a combination of computational, in vitro and ex vivo approaches in his work. Dr. Jankowski received his Ph.D. from Rutgers University, NJ and was subsequently selected for the highly competitive Commissioner’s Fellowship program at the FDA. His research has been published in high impact journals such as Nature and Nature Chemical Biology.
OC 31.4 - Novel Factor Xa agents that restore hemostasis in mice treated with apixaban
Monday, June 26, 2023
11:30 – 11:45 ET